clinical trial
Business
Intercept Pharmaceuticals Inc (ICPT) Surges 281% on Liver Drug Test Results
The stock price of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) skyrocketed by more than 281% after the company reported that clinical trial of its liver drug, obeticholic acid (OCA) was stopped early by Data Safety Monitoring...
